Business Expectations of the Manufacturing Sector: Singapore EDB

Singapore: Biomedical Manufacturing Business Expectations of the Manufacturing Sector: Singapore EDB

24.05.2021Editor: Ahlam Rais

The Singapore Economic Development Board (Singapore EDB) has stated in its recent release the country’s business sentiments for April – September 2021. It further mentions that the biomedical manufacturing cluster expects a positive business environment for the above-mentioned period while the chemicals cluster expects output to increase in the next quarter.

Related Vendors

AZO GmbH + Co. KG

Maag Pump Systems AG

TRM Filter d.o.o.

The petroleum and petrochemical segments anticipate a decline in output in the next quarter, in view of planned shutdowns for maintenance.
(Source: Pixabay)

Raffles City Tower/Singapore – Singapore’s manufacturing sector expects improved business conditions in the next six months, as ongoing Covid-19 vaccinations across countries continue to raise global economic prospects. A weighted 41 % of manufacturers anticipate business conditions to improve while a weighted 3 % foresee a weaker business outlook. Overall, a net weighted balance of 38 % of manufacturing firms anticipate a favorable business situation for the period April – September 2021, compared to the first quarter, states a release by the Singapore Economic Development Board.

Within the manufacturing sector, a net weighted balance of 32 % of firms in the biomedical manufacturing cluster expect a positive business environment for the period April – September 2021, in anticipation of higher overseas orders in both the pharmaceuticals and medical technology segments.

Business expectations for the next three and six months by the industry.
(Source: Singapore Economic Development Board)

Output Forecast for April – June 2021

A net weighted balance of 53 % of firms in the biomedical cluster expect production level to increase in the second quarter of 2021 compared to the preceding quarter. The pharmaceuticals segment forecasts increased production of active pharmaceutical ingredients and biological products while firms in the medical technology segment project higher output of medical devices for Covid-19 and non-Covid-19 uses.

According to the release, the chemicals cluster expects output to increase in the next quarter, supported by a net weighted balance of 2 % of firms. This is largely attributed to the specialties segment which projects higher output of mineral oil additives to meet improved export demand. The petroleum and petrochemical segments anticipate a decline in output in the next quarter, in view of planned shutdowns for maintenance.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Stand vom 23.03.2021

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.

(ID:47428701)